NandroRapid

Nandrolone Phenylpropionate 100mg

What is NandroRapid (Nandrolone Phenylpropionate) 100mg?

NandroRapid is a pharmaceutical formulation containing Nandrolone Phenylpropionate as its active ingredient, with each vial providing a concentration of 100mg. Classified as an anabolic steroid, NandroRapid is specifically designed for the treatment of various medical conditions, encompassing anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure, Turner's syndrome, and prophylaxis of hereditary angioedema. Nandrolone Phenylpropionate plays a pivotal role in addressing these diverse medical conditions.

Indications:

1. Anemias: NandroRapid is indicated for the treatment of anemias, characterized by a reduction in red blood cell count or hemoglobin levels. Nandrolone Phenylpropionate, with its erythropoietic properties, stimulates the production of red blood cells, enhancing oxygen-carrying capacity and alleviating symptoms associated with anemia.

2. Breast Carcinoma: In the context of breast carcinoma treatment, NandroRapid is prescribed to provide anabolic support, aiming to address symptoms and improve the overall well-being of patients undergoing breast cancer treatment.

3. Hereditary Angioedema: NandroRapid is indicated for the treatment of hereditary angioedema, a genetic disorder characterized by episodes of severe swelling in various parts of the body. Nandrolone Phenylpropionate may help reduce the frequency and severity of these episodes in individuals with hereditary angioedema.

4. Antithrombin III Deficiency: NandroRapid is utilized in the treatment of antithrombin III deficiency, a hereditary disorder that increases the risk of blood clot formation. Nandrolone Phenylpropionate may contribute to the management of coagulation abnormalities associated with antithrombin III deficiency.

5. Fibrinogen Excess: NandroRapid is indicated for addressing fibrinogen excess, a condition characterized by elevated levels of fibrinogen in the blood. By modulating fibrinogen levels, Nandrolone Phenylpropionate may play a role in the prevention or management of conditions associated with fibrinogen excess.

6. Growth Failure and Turner's Syndrome: NandroRapid is prescribed for the treatment of growth failure in children and adolescents, as well as in individuals with Turner's syndrome. Nandrolone Phenylpropionate's anabolic properties contribute to the promotion of growth and development in these populations.

7. Prophylaxis of Hereditary Angioedema: NandroRapid is indicated for the prophylaxis of hereditary angioedema, aiming to prevent or reduce the frequency and severity of episodes in individuals at risk of this genetic disorder.

How does it work?

Nandrolone Phenylpropionate, the active component in NandroRapid, is an anabolic steroid that functions by binding to androgen receptors in various tissues, including muscles, bones, and hematopoietic cells. This binding initiates a cascade of cellular events that result in increased protein synthesis, erythropoiesis, and the modulation of certain clotting factors. These effects contribute to the therapeutic actions of NandroRapid in addressing the diverse medical conditions mentioned.

Dosage and Administration:

The recommended dosage and administration of NandroRapid depend on the specific medical indication, the severity of the condition, and individual patient response. Healthcare professionals closely monitor the patient's response to treatment, adjusting the dosage as necessary for optimal therapeutic benefits.

Onset of Action:

The onset of NandroRapid's effects varies based on the specific medical indication being addressed. In conditions such as anemias, growth failure, and hereditary angioedema, noticeable improvements may take time and require consistent use.

Duration of Action:

The duration of NandroRapid's effects is sustained with regular use, contributing to the ongoing management of various medical conditions such as anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure, Turner's syndrome, and prophylaxis of hereditary angioedema. Regular medical check-ups are essential to assess the ongoing effectiveness of NandroRapid and adjust the treatment plan as needed.

Food and Absorption:

NandroRapid is typically administered through intramuscular injection, and its absorption is not significantly influenced by food intake. However, adherence to prescribed administration guidelines is crucial for achieving optimal therapeutic outcomes.

Presentation

Each carton contains 10 ampoules of 1ml (100mg/ml) or one vial of 10ml (100mg/ml)

Old Pack Design: